Clinical and Public Health Interventions & Trials

Evidence & Translation

Testing healthcare interventions with randomised controlled trials to improve the health and wellbeing, including a focus on women, babies and their families. 

MCHRI brings considerate skills in clinical trials design, delivery and analysis.

Gestational diabetes is a growing burden worldwide and has a significant impact on health services. Around one in eight pregnant women will experience gestational diabetes, seriously affecting the future health of women and their children.

This platform currently involves two clinical trial projects:

The Treatment Of Booking Gestational diabetes Mellitus Study - TOBOGM

This large multicentre international study is funded by the NHMRC and aims to investigate whether diagnosing and treating pregnant women prior to 20 weeks with gestational diabetes benefits the health of mums and their babies.

The study is testing 4000 women less than <20 weeks gestation across 18 hospitals

  • Campbelltown/Camden Hospitals, South Western Sydney – Lead-site
  • Monash Health/MCHRI, Melbourne
  • Liverpool Hospital, South Western Sydney
  • Bankstown-Lidcombe Hospital, South Western Sydney
  • Canberra Hospital
  • Westmead Hospital, Western Sydney
  • Blacktown Hospital, Western Sydney
  • Nepean Hospital, Western Sydney
  • Women’s & Children’s Hospital, Adelaide
  • Flinders Medical Centre, Bedford Park, SA
  • Lyell McEwin Hospital, Elizabeth Vale, SA
  • Royal Prince Alfred Hospital, Sydney
  • Fairfield Hospital, South Western Sydney
  • Fiona Stanley Hospital, Western Australia
  • Royal Brisbane and Women’s Hospital, Queensland
  • University of Vienna, Austria
  • Orebro University, Sweden
  • Royal Melbourne Hospital, Victoria
Bump to Baby and Me

A multifaceted program of work undertaking a randomised controlled trial to test a novel healthcare intervention during pregnancy and the first year after birth. This study is investigating whether remotely delivered lifestyle programs can limit growing health challenges of obesity and diabetes.  It is full recruited as of March 2022 with ongoing data collection.

Read more: